Influenza Vaccine: Clinical Trials

2 trials for Influenza Vaccine, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 unknown. 2 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 32Completed 1, Unknown 1

Follow Influenza Vaccine: new trials by email Literature Review of Influenza Vaccine trials Research Report on Influenza Vaccine

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study to Evaluate the Efficacy and Safety of GC3110A in Healthy Infants From 6 Months to 35 Months of Age
GC3110A, GCFLU Pre-filled syringe inj. - Influenza Vaccine
Phase 3UnknownGreen Cross Corporation2602017-09-302017-09-18
Efficacy and Safety of Influenza Vaccine During Sarcoidosis
Seasonal influenza vaccine available for the 2012-2013 vaccine campaign - Sarcoidosis, Influenza Vaccine
Phase 3CompletedAssistance Publique - Hôpitaux de Paris1902012-10-012025-11-20

Narrower conditions

Influenza, Human (2)  ·  Sarcoidosis (1)

Broader conditions

Infections (2)  ·  Orthomyxoviridae Infections (2)  ·  RNA Virus Infections (2)  ·  Respiratory Tract Diseases (2)  ·  Respiratory Tract Infections (2)  ·  Virus Diseases (2)  ·  Hemic and Lymphatic Diseases (1)  ·  Hypersensitivity (1)  ·  Hypersensitivity, Delayed (1)  ·  Immune System Diseases (1)  ·  Lymphatic Diseases (1)  ·  Lymphoproliferative Disorders (1)

Sponsors

Assistance Publique - Hôpitaux de Paris (1)  ·  Green Cross Corporation (1)

Countries

France (1)  ·  South Korea (1)

Top investigators

Claire Le Jeunne, MD, PhD (1)

Results publications

PMID 33736920